These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22591803)

  • 21. Structural elucidation of metabolites of tanshinone I and its analogue dihydrotanshinone I in rats by HPLC-ESI-MSn.
    Wang M; Dai H; Li X; Li Y; Wang L; Xue M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(13-14):915-24. PubMed ID: 20338833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
    Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
    J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of impurities in polymyxin B and colistin bulk sample using liquid chromatography coupled to mass spectrometry.
    Van den Bossche L; Van Schepdael A; Chopra S; Hoogmartens J; Adams E
    Talanta; 2011 Feb; 83(5):1521-9. PubMed ID: 21238747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel protocol for the preparation of sodium tanshinone sulphonates by direct ultrasound-assisted sulphonation of the crude extract of the roots of Salvia miltiorrhiza Bunge and following counter-current chromatography purification.
    Zeng L; Wu D; Wu S
    Phytochem Anal; 2011; 22(5):424-31. PubMed ID: 21465597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semi-preparative isolation and structural elucidation of an impurity in citalopram by LC/MS/MS.
    Raman B; Sharma BA; Ghugare PD; Karmuse PP; Kumar A
    J Pharm Biomed Anal; 2009 Oct; 50(3):377-83. PubMed ID: 19556091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous determination of tanshinone IIA and its three hydroxylated metabolites by liquid chromatography/tandem mass spectrometry.
    Li P; Wang GJ; Li J; Hao HP; Zheng CN
    Rapid Commun Mass Spectrom; 2006; 20(5):815-22. PubMed ID: 16470728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural identification and characterization of impurities in ceftizoxime sodium.
    Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of impurities in semi-synthetic vinorelbine bitartrate by HPLC-MS with mass spectrometric shift technique.
    Cao X; Tai Y; Sun C; Wang K; Pan Y
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):39-45. PubMed ID: 16085133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms.
    Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K
    J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ion-pair reversed-phase HPLC: assay validation of sodium tanshinone IIA sulfonate in mouse plasma.
    Mao SJ; Hou SX; Liang Z; Bi YQ; Wu Y; Li H; Jin H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):163-8. PubMed ID: 16406380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium tanshinone IIA sulfonate derived from Slavia miltiorrhiza Bunge up-regulate the expression of prolactin releasing peptide (PrRP) in the medulla oblongata in ovariectomized rats.
    Xiao Y; Qing WX; Lan MS; Ying CB
    Biochem Pharmacol; 2006 Aug; 72(5):582-7. PubMed ID: 16846593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural studies of racecadotril and its process impurities by NMR and mass spectroscopy.
    Reddy KM; Babu JM; Sudhakar P; Sharma MS; Reddy GS; Vyas K
    Pharmazie; 2006 Dec; 61(12):994-8. PubMed ID: 17283655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
    Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A
    Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and identification of a major impurity in a new bulk drug candidate by preparative LC, ESI-MS(n), LC-MS-MS, and NMR.
    Li N; Yang J; Qin F; Li F; Gong P
    J Chromatogr Sci; 2007 Jan; 45(1):45-9. PubMed ID: 17254383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of a potential process related impurity of phenazopyridine HCl by preparative HPLC followed by MS-MS and 2D-NMR spectroscopy.
    Rao RN; Maurya PK; Raju AN
    J Pharm Biomed Anal; 2009 Jul; 49(5):1287-91. PubMed ID: 19376664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a novel process-related impurity in commercial bendazac lysine eye drops by LC-ESI-QTOF/MS/MS and NMR.
    Zhu P; Yang W; Hong L; Cheng Q; Luo L; He J; Chen J
    J Pharm Biomed Anal; 2015 Mar; 107():437-43. PubMed ID: 25666544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
    Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K
    J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural identification and characterization of potential impurities of pantoprazole sodium.
    Reddy GM; Bhaskar BV; Reddy PP; Ashok S; Sudhakar P; Babu JM; Vyas K; Mukkanti K
    J Pharm Biomed Anal; 2007 Oct; 45(2):201-10. PubMed ID: 17629653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
    Thomas S; Chandra Joshi S; Vir D; Agarwal A; Rao RD; Sridhar I; Xavier CM; Mathela CS
    J Pharm Biomed Anal; 2012 Apr; 63():112-9. PubMed ID: 22361658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.